chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nerve damage on my right arm; Pain in the Left Arm radiating to the Neck and Jaw line  (After Second Shot), Felt like he was Hit by a Truck (After Second Shot); Nausea (After Second Shot); Fatigue (After Second Shot); Muscle Pain  (After Second Shot); This spontaneous case was reported by a consumer and describes the occurrence of NERVE INJURY (nerve damage on my right arm), PAIN (Pain in the Left Arm radiating to the Neck and Jaw line  (After Second Shot), Felt like he was Hit by a Truck (After Second Shot)), NAUSEA (Nausea (After Second Shot)), FATIGUE (Fatigue (After Second Shot)) and MYALGIA (Muscle Pain  (After Second Shot)) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PAIN (Pain in the Left Arm radiating to the Neck and Jaw line  (After Second Shot), Felt like he was Hit by a Truck (After Second Shot)), NAUSEA (Nausea (After Second Shot)), FATIGUE (Fatigue (After Second Shot)) and MYALGIA (Muscle Pain  (After Second Shot)). On an unknown date, the patient experienced NERVE INJURY (nerve damage on my right arm). On 18-Apr-2021, NAUSEA (Nausea (After Second Shot)) had resolved. At the time of the report, NERVE INJURY (nerve damage on my right arm) and MYALGIA (Muscle Pain  (After Second Shot)) outcome was unknown and PAIN (Pain in the Left Arm radiating to the Neck and Jaw line  (After Second Shot), Felt like he was Hit by a Truck (After Second Shot)) and FATIGUE (Fatigue (After Second Shot)) had not resolved.            Concomitant product use was not provided by the reporter. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-116669 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: New event was added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116669:
Received flu shot on 11/06/08.  The next day (11/07/08) around 11 am, left arm was hot, red, painful and swollen to 1 inch above elbow. Saw dr around  1 pm and was placed on antibiotics, Benedryl and Tylenol.  On 11/08/08 swelling spread into the chest area and down past the elbow of left arm. Area was hot, red and painful.  Saw Dr.at 11 am on 11/08/08. Placed on steroid medication.
105 T X 12 hrs-did not respond to APAP. 104 fever X 12 hrs-responded to ibuprofen.Cont crying X > 24 hrs. @ time of report still requiring antipyretics.
Suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 12-Jul-2023 This case was reported the patient via interactive digital media. The patient received a pf or jab and now (at the time of reporting) the patient had shingles. The patient was really struggled with it. The reporter stated it was miserable, as awful jab injury. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up not possible as no contact details provided.
patient was given a dose under the age of 16.  No adverse events reported aside from the age at vaccination.
DTAP and IPV given 07/28/2005 PM.  Mom called the clinic 07/29/2005 6:00PM child complained of left thigh, itching and hurting, when she checked it, noted red circle area 2 x 3 inch - warm to touch - clinic notified - patient told to come to clinic.  Boctrin, Benadryl cream, warm packs prescribed.
Pt recvd 1 dose of Engerix-B & 3 days later devel raised, red, itchy rash to face & 1 arm; also diarrhea; diarrhea treated w/Kaopectate; sx have partially resolved;
Began 11/21/2001 afternoon with T 100.4, abdominal pain and red, raised vesicles. Capules, scrbs 22 for limited to torso mildly pruritic.
This spontaneous report as received from nurse refers to a 12 month old male patient with no drug allergies and no pertinent medical history. On 07-MAY-2014 the patient was vaccinated with VARIVAX (Merck) (0.5 milliliter (ml), subcutaneous in the left thigh). On 07-MAY-2014, 5 minutes after the injection, the injection site turned a deep red and the physician drew a circle around it to help monitor any spreading. The nurse reported that the patient was administered BENADRYL and that thirty minutes later, the redness spread to the left buttock, then spread to the right buttock, the left thigh and up the lower back. The nurse reported that the patient "did not seem to be bothered by itching or pain". The nurse also stated that the physician administered 1 teaspoon of ORAPRED and the redness started to decrease. The causality was not reported. Additional information has been requested.
Room spinning unable to stand up; when attempting to stand vomitting uncontrollably; lasted 2-days; unable to walk or stand; crawled to make it to the bathroom; - Started Saturday evening, February 6 - Monday, February 8 when I went to urgent care
This spontaneous report as received from a 76 year old female patient (also the reporter) with high blood pressure, diabetes and endocarditis. The patient's medical history included prior cases of pneumonia. On 13-NOV-2013 the patient was vaccinated with PNEUMOVAX23 (dose, lot and expiry date unknown), Metformin (manufacturer unknown) aspirin (manufacturer unknown), Coreg, Lipitor, Iron (unspecified) (iron supplements, manufacturer unknown and Doxycycline (manufacturer unknown). On 13-NOV-2013, 1 day after onset of therapy the patient developed soreness and pain in the shoulder and arm, and the patient stated she could not sleep. The outcome of events was reported as resolving. As treatment for the events, the patient took TYLENOL (unspecified manufacturer, dose, frequency). The patient had contacted the pharmacist by phone to seek medical attention. Additional information has been requested.
The patient called the pharmacy saying the injection site was swollen red and hot. The patient said her provider diagnosed it as cellulitis. I asked how she is doing, she said it's a little better but that she will not start antibiotics until the next day. The injection was three days ago. The patient states I did not use alcohol wipes. I am certain I used alcohol wipes as I always do in my immunization routine (wipe, let it dry, barrier band-aid, then inject), perhaps the patient did not see me wipe the skin. I messaged the Pharmacy Manager to follow up with the patient tomorrow.
20 mins after vaccine administration felt dizzy, brushed it off, went to work and 20 mins after initial symptoms became more dizzy and had difficulty getting her words out when talking to her customer; felt like she was going to faint  She did not faint, but was able to regain composure and drive home. States she has no memory of what else happened after arriving home. Fell asleep and woke up the next morning back at baseline.
I began having severe left arm pain, down to my hand, four hours after the vaccination.  This pain subsided after a number of hours.  I began to experience moderate discomfort in my left shoulder, upper arm, armpit and pectoral muscle area, which made sleeping uncomfortable.  The next day, March 6, I experienced moderate malaise, continued pain as described above, and increasing pain and a feeling of swelling or fullness in my armpit and pectoral area.  It felt like the armpit lymph node and the sentinel lymph nodes on the front of my left shoulder were swollen and irritated.  On Saturday March 7 and Sunday, March 8, I experienced no malaise, but the feeling of fullness and painful lymph nodes increased.  On Sunday afternoon, at about 4 PM, I removed my blouse and saw that was looked like a large bruise had formed on my left breast and a paler bruise appearing discoloration was under my arm.  the feeling of fullness in my lymph nodes and armpit had subsided, but still remained to a certain extent.  When I got up at 6:30 AM on March 9, I observed that what had appeared bruise like had become quite red.  The discolored area was smaller, but the underside of my breast had a red somewhat lumpy appearing rash like skin effect. This rash does not itch.  I still have a feeling of fullness in my armpit and my shoulder and pectoral muscles are stiff and moderately sore, with normal range of motion.  Otherwise, I feel well, with no fever or pain or rash anywhere else.  I feel fairly normal, except for some concern over this side effect
Developed sudden onset of tinnitus (constant ringing in both ears) 12 days after receiving Moderna booster vaccine.  Symptoms have not resolved and continue.
headache, dizziness, stiff and sore everywhere starting approx 8-12 hours after receiving the Menactra vaccine
The following morning I felt mild flu like symptoms and very low energy.  While at working my right upper ankle/ lower knee became extremely sore for no reason.  A mild headache and upper respiratory irritation also occurred. My right arm at injection point was extremely sore.  I figured it was a immune response and didn?t get too worried.  These symptoms have persisted. Hopefully will subside soon
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Born with one kidney but fully functional" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300186341 Same patient, different drug, different event;
about 430PM pt began choking, couldn't breathe, vomited mucous, child was screaming, time unk; took pt to the ER in an ambulance; ER said according to mom had a react to pertussis; pt was sweaty & afebrile, chest x-ray & blood work done;
Patient trying to get 2nd dose at 52 days; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient trying to get 2nd dose at 52 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient trying to get 2nd dose at 52 days).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient complained that her arm got very red and swelling. She experience pain in the arm next day after vaccination. Pharmacist observe the site of injection and notice that her arm is red and bruised all of the to the elbow. Also patient complained of hit at the site of injection.
2 to 3 inch raised fevered circular whelp stated 7 days after injection. Took Zyrtec and Chlorphenamine and put a cold compress on site.
Pt recv'd 1st injection of Lymerix w/ no reported event. In Aug 1999, pt recv'd his 2nd dose of Lymerix. Pt then dvlped sharp, debilitating pain in his feet, hips, & shoulders.
This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 28-year-old female patient (not pregnant) received the 1st dose of BNT162B2 (Comirnaty, batch/lot# unknown), at the age of 28, in left arm, on Dec 16, 2021, single dose, for COVID-19 immunisation. Medical history included COVID-19 (unspecified if ongoing). Notes: Prior to vaccination, was the patient diagnosed with COVID-19? Yes. There were no concomitant medications. The patient reported alopecia/have been losing hair by the fistfuls/every shower and every hair brush resulted in a softball size wads of hair loosened from scalp, onset Dec 20, 2021, outcome of not recovered. No therapeutic measures taken as a result of alopecia. Additional information: The patient has no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The lot number for BNT162B2 not provided and will be requested during follow-up.
Received seasonal influenza vaccine (Flumist- Medimune) on 27 October 2011 during the flu clinic.  The patient's wife stated that within 24 hours he began to have difficulty breathing and twitching. She took him to the Hospital where he was seen by a medical provider and released for a viral infection. The next day the patient had a full blown grand-mal seizure.
Fever for 1-2 days, body aches, respiratory symptoms, body rash. Symptoms still present, although improving.
Since 13 December he has complained of daily recurrent episodes of rashes described as fraised, red, itchy whelts which can occur anywhere on his body but typically occur at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours and resolve without post-inflammatory changes. He notes involvement of his palms and soles. He also endorses prior episode of facial and throat swelling which he feels caused wheezing and difficulty breathing; when he was evaluated in the ER no wheezing was noted. He otherwise denies pulmonary, GI, neurologic, and cardiovascular symptoms. Episodes not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. He received his COVID19 vaccine booster dose on 4 December, 9 days prior to onset of symptoms. He has used oral antihistamines with partial control of symptoms. His symptoms led him to present to the ER on 14 and 16 December. With his first visit he received Benadryl and prednisone with transient improvement in his symptoms, but due to recurrence of his rash and facial and throat swelling he again presented to the ER two days later where he received epinephrine, IV Benadryl, and IV Decadron with resolution of his symptoms. He was again seen in the ER on 25 December for palpitations, elevated blood pressure, dizziness, and mild, transient shortness of breath felt to be secondary to his Prednisone course. He denies constitutional symptoms.
PATIENT SAID HIS ARM FEELS "DEAD" SINCE HE RECEIVED HIS FLUZONE HIGH DOSE AND IT HAS BEEN FOR 6 WEEKS.
Headache,  runny nose, congestion,  cough, body aches, fatigue.  Scratch throat and cough started 3 days after receiving shot, runny nose, congestion,  body aches and fatigue started 5 days after shot.
During the night after I got the vaccine I got up to go to the bathroom. I got sick to my stomach and I started throwing up. I crawled back to bed but I got sick again and I woke my wife up. She noticed that I was not speaking clearly and she could not understand what I was saying. She was worried and she called 911. The ambulance came right away and they took me to the hospital within an hour of the first symptoms. I was diagnosed with a stroke right away and I was given tPA. I was in ICU for a few days and then moved to a regular room. After that I was moved to a rehabilitation facility. I have been having some vision problems as well as a problem with controlling my blood pressure. I have also been diagnosed with Parkinson's since I got the vaccine. The doctor explained that my Rheumatoid Arthritis may have been triggered to cause extra problems. I was in rehab until July of 2021 but my recovery has been slow. Some days are better than others and my speech is better sometimes than others.
I received my shot at facility. After 4 days, I have a rash similar to poison ivy on my left arm. It starts from my shoulder down to my wrist. I have severe arm pain as well
No adverse events. No treatment other than Tylenol q 4 hours PRN fever and pain.
This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 21-year-old female patient who received MENVEO (batch number 151501, expiry date unknown). On 7th June 2016, the patient received MENVO .5 ml. In June 2016, less than a week after receiving MENVEO, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to MENVEO. Additional details were provided as follows: The healthcare professional reported that a number of patients received the MENVEO vaccine and experienced severe pain at injection site in the arm. The healthcare professional only had information for 3 patients, they all reported to have pain up to a week after administration. No expiration date was provided for the vaccine. This case had been linked with cases US2016GSK102324 and US2016GSK102325, reported by the same reporter.
No adverse event; Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.) and NO ADVERSE EVENT (No adverse event) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.).    Concomitant product use was not provided by the reporter.  Pharmacist reported that, they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date.  The beyond use by date for lot number 053C21A was 01-Jul-2021.  Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document received includes no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
pt recv vax 7MAY96 & exp vomiting, fatigue, fever;sx resolved w/in 2 days;reporter plans to repeat serological testing & include an anti-HBcAg test;
Patient reporting that in the morning after the injection she experienced fever, cold sores in mouth, joint discomfort, emesis for 3 days and a headache in the back of her head/spine area.
Severe multi focal arthropathy affecting bilateral knees, hips, elbows, and shoulders. Intermittent mild bilateral finger arthropathy too. Severe morning pain and stiffness that lasted approximately 5 months. Tough to get out of bed every morning. The symptoms would improve over the course of the day. Symptoms would recur the next morning.
1/2/22 Short of breath.  This started around Christmas.  It is gradually worsening.  Coughing.  Had a negative at home Covid test.  The coughing is severe.  Shortness of breath is moderate to severe.  Gradually worsening.  Productive at times.  He has no chest pain pressure or tightness.  No pain with taking a breath.  No personal or family history of clots or dissection or heart disease.  No abdominal pain.  No back pain.  No swelling or pain in the arms or the legs.  No trauma.  No headaches or neck pain.  No fevers. Review of Systems  Constitutional: Positive for activity change, appetite change, chills and fatigue. Negative for fever.  HENT: Positive for congestion.  Review of Systems   Negative for nosebleeds, neck pain and neck stiffness.   Eyes: Negative for visual disturbance.  Respiratory: Positive for cough and shortness of breath. Negative for chest tightness.   Cardiovascular: Negative for chest pain and leg swelling.  Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting.  Genitourinary: Negative for difficulty urinating and dysuria.  Musculoskeletal: Negative for back pain and gait problem.  Skin: Negative for rash.  Neurological: Negative for dizziness, tingling and headaches.  Hematological: Does not bruise/bleed easily.  Psychiatric/Behavioral: Negative for agitation.  1/24/22  REASON FOR HOSPITALIZATION COVID-19 pneumonia causing hypoxemia acute respiratory failure     FINAL DIAGNOSES 1.  Acute respiratory failure with hypoxemia secondary to COVID-19 pneumonia and pulmonary embolus 2. large pulmonary emboli and bilateral lower DVTs 3.  Bacteremia--causing severe sepsis 4.  A. fib with RVR 5.  History of hypertension 6.  Acute kidney injury  7.  Severe sepsis with organ failure kidney and respiratory 74yo gentleman with a PMH of HTN, HLD, GERD, and arthritis who was admitted on 1/3 for acute respiratory failure wit hypoxia 2/2 PE and pneumonia..  Patient was intubated on 1/9/2022. Continue Decadron and remdesivir, baricitinib (start date 1/7).  Completed Unasyn and azithromycin.  Patient started displaying leukocytosis had positive blood cultures on 1/18/2022 was started restarted on cefepime and switched to Unasyn and now on Zosyn ID was consulted.  Patient had his central line replaced on 1/20/2022.  Patient's oxygen requirements increased to 85%.  He is showing kidney failure with his creatinine elevated this morning further at 2.59.  Family and patient's wife have decided to make him comfort care only once all family has arrived.  The following morning family had all catheter to stated decided on terminal extubation patient was extubated and passed peacefully On 1/24/2022 at 11:25 AM
My arm locked no mobility. Excruciating pain. Could not sleep from the pain. Could not fulfill my gym membership I had signed up for. Pain was severe